The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical anti-lymphoma activity and toxicity of T cells expressing a novel anti-CD19 chimeric antigen receptor with fully-human variable regions.
 
Jennifer N. Brudno
Stock and Other Ownership Interests - Gilead Sciences (I)
 
Steven D. Hartman
No Relationships to Disclose
 
Stefania Pittaluga
No Relationships to Disclose
 
David Stroncek
No Relationships to Disclose
 
Norris Lam
No Relationships to Disclose
 
Jennifer Ann Kanakry
No Relationships to Disclose
 
Steven Zivko Pavletic
Research Funding - Actelion (Inst); Celgene (Inst); Lilly (Inst)
 
Lekha Mikkilineni
No Relationships to Disclose
 
Mohammadhadi Bagheri
No Relationships to Disclose
 
Mark J. Roschewski
No Relationships to Disclose
 
Robert M. Dean
No Relationships to Disclose
 
Jeremy J. Rose
No Relationships to Disclose
 
Rashmika Patel
No Relationships to Disclose
 
Brenna G. Hansen
No Relationships to Disclose
 
Ronald Gress
No Relationships to Disclose
 
James Kochenderfer
Research Funding - Bluebird Bio (Inst); Kite/Gilead (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents licensed to multiple companies including Kite Pharma related to CAR T-cell technologies.